Annual Total Long Term Liabilities
$0.00
-$7.04 M-100.00%
December 31, 2023
Summary
- As of February 23, 2025, MRKR annual total long term liabilities is $0.00, with the most recent change of -$7.04 million (-100.00%) on December 31, 2023.
- During the last 3 years, MRKR annual total long term liabilities has fallen by -$11.87 million (-100.00%).
- MRKR annual total long term liabilities is now -100.00% below its all-time high of $11.87 million, reached on December 31, 2020.
Performance
MRKR Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 23, 2025, MRKR quarterly total long term liabilities is $0.00, unchanged on September 30, 2024.
- Over the past year, MRKR quarterly long term liabilities has stayed the same.
- MRKR quarterly long term liabilities is now -100.00% below its all-time high of $11.95 million, reached on September 30, 2020.
Performance
MRKR Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
MRKR Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | 0.0% |
| 3 y3 years | -100.0% | 0.0% |
| 5 y5 years | 0.0% | 0.0% |
MRKR Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | -100.0% | at low |
| 5 y | 5-year | -100.0% | at low | -100.0% | at low |
| alltime | all time | -100.0% | at low | -100.0% | at low |
Marker Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $0.00(0.0%) |
| Jun 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(0.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2023 | - | $0.00(0.0%) |
| Jun 2023 | - | $0.00(-100.0%) |
| Mar 2023 | - | $6.82 M(-3.1%) |
| Dec 2022 | $7.04 M(-37.4%) | $7.04 M(-2.6%) |
| Sep 2022 | - | $7.23 M(-33.2%) |
| Jun 2022 | - | $10.82 M(-2.0%) |
| Mar 2022 | - | $11.04 M(-1.9%) |
| Dec 2021 | $11.25 M(-5.2%) | $11.25 M(-1.6%) |
| Sep 2021 | - | $11.43 M(-1.2%) |
| Jun 2021 | - | $11.57 M(-1.3%) |
| Mar 2021 | - | $11.72 M(-1.3%) |
| Dec 2020 | $11.87 M(+4135.7%) | $11.87 M(-0.7%) |
| Sep 2020 | - | $11.95 M(+32.4%) |
| Jun 2020 | - | $9.03 M(+3891.7%) |
| Mar 2020 | - | $226.10 K(-19.3%) |
| Dec 2019 | $280.20 K(>+9900.0%) | $280.20 K(-16.0%) |
| Sep 2019 | - | $333.50 K(-13.4%) |
| Jun 2019 | - | $385.20 K(-11.5%) |
| Mar 2019 | - | $435.20 K(>+9900.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00 | $0.00(0.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2011 | - | $568.10 K(+12.6%) |
| Jun 2011 | - | $504.50 K(+13.9%) |
| Mar 2011 | - | $442.80 K(>+9900.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00(0.0%) |
| Jun 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Dec 2008 | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2007 | $0.00(-100.0%) | $0.00(-100.0%) |
| Mar 2005 | - | $443.70 K(+807.4%) |
| Jun 2000 | - | $48.90 K(0.0%) |
| Mar 2000 | - | $48.90 K |
| Dec 1999 | $48.90 K | - |
FAQ
- What is Marker Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Marker Therapeutics?
- What is Marker Therapeutics annual total long term liabilities year-on-year change?
- What is Marker Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Marker Therapeutics?
- What is Marker Therapeutics quarterly long term liabilities year-on-year change?
What is Marker Therapeutics annual total long term liabilities?
The current annual total long term liabilities of MRKR is $0.00
What is the all time high annual total long term liabilities for Marker Therapeutics?
Marker Therapeutics all-time high annual total long term liabilities is $11.87 M
What is Marker Therapeutics annual total long term liabilities year-on-year change?
Over the past year, MRKR annual total long term liabilities has changed by -$7.04 M (-100.00%)
What is Marker Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of MRKR is $0.00
What is the all time high quarterly long term liabilities for Marker Therapeutics?
Marker Therapeutics all-time high quarterly total long term liabilities is $11.95 M
What is Marker Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, MRKR quarterly total long term liabilities has changed by $0.00 (0.00%)